Literature DB >> 3128575

Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum.

J L Soto-Hernandez1, D Nunley, S Holtsclaw-Berk, S L Berk.   

Abstract

A selective medium with DNase test agar and incorporating vancomycin (10 micrograms/ml), trimethoprim (8 micrograms/ml), and amphotericin B (2 micrograms/ml) supported the growth of 305 Branhamella catarrhalis isolates. A modified toluidine blue O technique was used after 48 h of incubation in CO2 to overlay suspected B. catarrhalis colonies. A metachromatic color change was observed in 15 min, indicating DNase production. In 200 unselected sputum samples of hospitalized patients, this method was compared with routine microbiologic procedures; 31 B. catarrhalis isolates were recovered with the method, compared with 22 isolated from the clinical laboratory. This medium will be particularly useful for culture of sputum, which shows inflammatory cells and gram-negative diplococci on Gram-stained smears.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128575      PMCID: PMC266302          DOI: 10.1128/jcm.26.3.405-408.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Rapid method for determining the activity of microorganisms on nucleic acids.

Authors:  C D JEFFRIES; D F HOLTMAN; D G GUSE
Journal:  J Bacteriol       Date:  1957-04       Impact factor: 3.490

2.  Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity.

Authors:  R V Lachica; C Genigeorgis; P D Hoeprich
Journal:  Appl Microbiol       Date:  1971-04

3.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors:  S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

4.  Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.

Authors:  F Ahmad; D T McLeod; M J Croughan; M A Calder
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

5.  Acute maxillary sinusitis in children.

Authors:  E R Wald; G J Milmoe; A Bowen; J Ledesma-Medina; N Salamon; C D Bluestone
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

6.  A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract: with particular reference to Branhamella catarrhalis.

Authors:  J E Corkill; T Makin
Journal:  Med Lab Sci       Date:  1982-01

7.  Improvement of two toluidine blue O-mediated techniques for DNase detection.

Authors:  J R Waller; S L Hodel; R N Nuti
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

8.  Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.

Authors:  G V Doern; K G Siebers; L M Hallick; S A Morse
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

9.  In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.

Authors:  K G Sweeney; A Verghese; C A Needham
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

View more
  3 in total

Review 1.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

2.  Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; B Weise; A M Van den Abeele
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

3.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.